Greg Nuttall
Director/Board Member presso CLEAN ENERGY SPECIAL SITUATIONS CORP.
Patrimonio netto: 444 000 $ in data 29/02/2024
Profilo
Greg A.
Nuttall founded Cultural Research and Rubicon Investment Group.
Currently, he holds the position of President, Chief Executive Officer & Director at Woodland Biofuels, Inc. He is also on the board of Clean Energy Special Situations Corp.
In the past Mr. Nuttall occupied the position of Chief Executive Officer of Cultural Research and General Partner at Rubicon Investment Group.
Greg A.
Nuttall received a graduate degree from the University of Cambridge and a graduate degree from Osgoode Hall Law School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
31/07/2023 | 30 000 ( 0.43% ) | 316 500 $ | 29/02/2024 | |
24/03/2023 | 170 000 ( 0.24% ) | 127 500 $ | 29/02/2024 |
Posizioni attive di Greg Nuttall
Società | Posizione | Inizio |
---|---|---|
CLEAN ENERGY SPECIAL SITUATIONS CORP. | Director/Board Member | 15/05/2023 |
Woodland Biofuels, Inc.
Woodland Biofuels, Inc. Chemicals: SpecialtyProcess Industries Woodland Biofuels, Inc. develops a process technology to produce cellulosic ethanol from renewable biomass. It builds, owns, and operates cellulosic ethanol plants. Its technology eliminates the use of food to make ethanol by converting biomass, such as wood and crop waste into ethanol or other products. The company was founded by Antony G. Moran n 2000 and is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Precedenti posizioni note di Greg Nuttall
Società | Posizione | Fine |
---|---|---|
Swiss Medica, Inc.
Swiss Medica, Inc. Pharmaceuticals: MajorHealth Technology Swiss Medica, Inc. is a specialty pharmaceutical company focused on over-the-counter, clinically tested, patented and all-natural products that relieve chronic ailments. The company is engaged in the business of marketing and distributing proprietary bioscience health products with the focus on chronic ailments. Its goal is to bring natural, healthy, clinically-proven and proprietary products that address chronic ailments into the mainstream food, drug and mass retail channels and out of their traditional market niche of specialty retailers. Swiss Medica, Inc. believes that it will increase the demand for bioscience health products since natural products are considered to be effective against many ailments and are more accessible than prescription medications. The company intends to support its O24 Pain Neutralizer, O24 Fibromyalgia and PMS Escape products with point-of-presence marketing, sampling, print and in-store advertisements, radio spots, and extensive use of public relations, including testimonials and endorsements from medical professionals and recognized celebrities. | Director/Board Member | 25/01/2005 |
ZYUS LIFE SCIENCES CORPORATION | Director/Board Member | - |
Cultural Research | Chief Executive Officer | - |
Rubicon Investment Group
Rubicon Investment Group Investment Banks/BrokersFinance Rubicon Investment Group provides investment services. The Canadian company was founded by Greg A. Nuttall. | Founder | - |
Formazione di Greg Nuttall
University of Cambridge | Graduate Degree |
Osgoode Hall Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CLEAN ENERGY SPECIAL SITUATIONS CORP. | Finance |
Aziende private | 5 |
---|---|
Swiss Medica, Inc.
Swiss Medica, Inc. Pharmaceuticals: MajorHealth Technology Swiss Medica, Inc. is a specialty pharmaceutical company focused on over-the-counter, clinically tested, patented and all-natural products that relieve chronic ailments. The company is engaged in the business of marketing and distributing proprietary bioscience health products with the focus on chronic ailments. Its goal is to bring natural, healthy, clinically-proven and proprietary products that address chronic ailments into the mainstream food, drug and mass retail channels and out of their traditional market niche of specialty retailers. Swiss Medica, Inc. believes that it will increase the demand for bioscience health products since natural products are considered to be effective against many ailments and are more accessible than prescription medications. The company intends to support its O24 Pain Neutralizer, O24 Fibromyalgia and PMS Escape products with point-of-presence marketing, sampling, print and in-store advertisements, radio spots, and extensive use of public relations, including testimonials and endorsements from medical professionals and recognized celebrities. | Health Technology |
Phoenix Canada Oil Co. Ltd.
Phoenix Canada Oil Co. Ltd. Oil & Gas ProductionEnergy Minerals Phoenix Canada Oil Co. Ltd. engages in the development, production, and maintenance of oil and natural gas properties. It focuses on developing clean energy solutions based on water-derived hydrogen; and RaHydro Splitter, a molecular machine that mimics photosynthesis by utilizing visible light to dissociate hydrogen from ordinary water. The company was founded on November 25, 1944 and is headquartered in Toronto, Canada. | Energy Minerals |
Rubicon Investment Group
Rubicon Investment Group Investment Banks/BrokersFinance Rubicon Investment Group provides investment services. The Canadian company was founded by Greg A. Nuttall. | Finance |
Cultural Research | |
Woodland Biofuels, Inc.
Woodland Biofuels, Inc. Chemicals: SpecialtyProcess Industries Woodland Biofuels, Inc. develops a process technology to produce cellulosic ethanol from renewable biomass. It builds, owns, and operates cellulosic ethanol plants. Its technology eliminates the use of food to make ethanol by converting biomass, such as wood and crop waste into ethanol or other products. The company was founded by Antony G. Moran n 2000 and is headquartered in Toronto, Canada. | Process Industries |